The changing roles and targets for animal models of schizophrenia.
about
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia.How antipsychotics work-from receptors to reality.Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapineFunctional networks underlying latent inhibition learning in the mouse brain.Maternal household crowding during pregnancy and the offspring's risk of schizophreniaPro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia.Understanding antipsychotic "atypicality": a clinical and pharmacological moving targetNADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology.Neurotensin agonists as an alternative to antipsychotics.A brief review on recent developments in animal models of schizophreniaEmploying proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia.A model of antipsychotic action in conditioned avoidance: a computational approach.Coantagonism of glutamate receptors and nicotinic acetylcholinergic receptors disrupts fear conditioning and latent inhibition of fear conditioning.Expression of the CS- and US-pre-exposure effects in the conditioned taste aversion paradigm and their abolition following systemic amphetamine treatment in C57BL6/J mice.A computational model of the functional role of the ventral-striatal D2 receptor in the expression of previously acquired behaviors.Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats.Syntaxin 1B contributes to regulation of the dopaminergic system through GABA transmission in the CNS.A rat model for neural circuitry abnormalities in schizophrenia.Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia.Differential effects of acute amphetamine and phencyclidine treatment and withdrawal from repeated amphetamine or phencyclidine treatment on social interaction and social memory in rats.Multiple 'hits' during postnatal and early adulthood periods disrupt the normal development of sensorimotor gating ability in rats.
P2860
Q30428213-D00A1B96-9CBF-446A-AA96-A243DA531777Q30454141-B75B99DF-DEC4-4A73-99DE-F14516EB7E49Q30455798-0F3972FD-0285-4D7A-8C95-CEEA78D464BBQ30457477-B2A3C7A2-F16A-4436-BE2E-38483A22B503Q30458533-B4EEB7E3-D156-4544-B9C7-1E78FFB6D920Q30493079-14716392-CE98-49C9-B561-7BDCF6304042Q34339873-EB3845D1-F0B8-4E94-85B9-6399423EC9C1Q34926526-8ABCAB0D-D756-4DB2-8369-15DCCD4EDA86Q35200831-09D33DA1-6E70-42DB-8965-C7D0A5C8BD5DQ36001558-EA9EC5AE-D9FF-49A9-8121-C7AD26B97897Q36120748-F2DDB96A-C811-4A83-BE75-542138C4B8ACQ37918345-A3E9EAEE-B971-442A-BC2E-166756B35AB8Q38672722-89217462-E761-4008-92AB-6AD3356BD908Q40527909-43A625DF-1277-4C63-9ECD-FDA920399B79Q41842706-11FA5481-6686-4C0D-9DA6-03395BDBB99FQ44967609-2E55ED20-DDE9-4843-BB25-3B742C569EB6Q45273748-942C0033-529D-4328-8EBA-FA21E7B23A93Q46090401-304E2FCF-E892-481E-9D7E-5337E33E8F50Q47400866-0F3144AB-30DD-4346-B8AC-153CDD4E8326Q48218870-82FEB1A4-5088-4164-B24A-20B7438D920AQ50442482-BB8397DB-2D4A-4C85-8F42-DD440A8B97ADQ50952803-EAFBCDCC-74D6-4616-8752-3CCB33D623DAQ51857267-519F371E-3224-4231-A796-0489C8E98769
P2860
The changing roles and targets for animal models of schizophrenia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The changing roles and targets for animal models of schizophrenia.
@ast
The changing roles and targets for animal models of schizophrenia.
@en
The changing roles and targets for animal models of schizophrenia.
@nl
type
label
The changing roles and targets for animal models of schizophrenia.
@ast
The changing roles and targets for animal models of schizophrenia.
@en
The changing roles and targets for animal models of schizophrenia.
@nl
prefLabel
The changing roles and targets for animal models of schizophrenia.
@ast
The changing roles and targets for animal models of schizophrenia.
@en
The changing roles and targets for animal models of schizophrenia.
@nl
P1476
The changing roles and targets for animal models of schizophrenia.
@en
P2093
P304
P356
10.1016/S0006-3223(01)01286-0
P407
P577
2001-12-01T00:00:00Z